Evidence map›Paper›PMID 41958460›Full record

ArticleFrontiers in cardiovascular medicine2026

Successful rescue of a high-risk pulmonary embolism using thrombolysis, extracorporeal membrane oxygenation, and percutaneous pulmonary thrombectomy: a case report.

Xia Meng, Dongsheng Wang, Guohui Liu, Mei Ding

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xia MengDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Dongsheng WangDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Guohui LiuDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Mei DingDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary embolism (PE) presenting with syncope as an initial symptom is a relatively uncommon condition with a comparatively high rate of mortality (47.5%) that is prone to misdiagnosis as other cardiac and pulmonary diseases. The European Society of Cardiology classifies acute PE with persistent hypotension as high-risk PE. Patients with syncope as the initial symptom often have persistent hypotension and hypoxemia. Although traditional therapeutic approaches, such as thrombolysis and anticoagulation, have limited efficacy in treating this type of acute PE, timely use of extracorporeal membrane oxygenation (ECMO) to stabilize hemodynamics and bridging with percutaneous pulmonary thrombectomy (PPT), is an effective method in cases of high-risk PE presenting with syncope as the initial symptom. In this report, we describe the case of a 48-year-old man with no history of previous cardiac or pulmonary diseases, who had experienced sudden syncope 3 days prior to admission. Following admission, he developed cardiogenic shock [heart rate 125 beats per min, systolic blood pressure (SBP) 87 mmHg, lactate 5.2 mmol/L]. Computed tomography pulmonary angiography revealed massive bilateral PE. Although thrombolytic therapy was promptly administered, the patient continued to experience persistent hypotension (SBP 67 mmHg) and refractory hypoxemia (SaO

Indexed as

case reportextracorporeal membrane oxygenationhemodynamic instabilityhigh-risk pulmonary embolismpercutaneous pulmonary thrombectomypulmonary embolismthrombectomythrombolytic therapy

Identifiers

PMID41958460
PMCPMC13057341

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.